OTC Morning Call » BCLI http://www.otcmorningcall.com Mon, 06 Sep 2010 07:12:26 +0000 http://wordpress.org/?v=2.9.2 en hourly 1 Resistance Was Not Reached http://www.otcmorningcall.com/2009/10/resistance-was-not-reached/ http://www.otcmorningcall.com/2009/10/resistance-was-not-reached/#comments Tue, 27 Oct 2009 13:40:50 +0000 Mike Cole http://otcmorningcall.com/?p=427 stockmarketflatBrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) was on our watch list as of last week but has been removed since it did not move to and break through resistance.

Again please note: we have not received any compensation nor do we own any shares of BCLI. Before you buy any stock be sure that you do your own DD.

]]> http://www.otcmorningcall.com/2009/10/resistance-was-not-reached/feed/ 0 BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) http://www.otcmorningcall.com/2009/10/brainstorm-cell-therapeutics-inc-otcbb-bcli/ http://www.otcmorningcall.com/2009/10/brainstorm-cell-therapeutics-inc-otcbb-bcli/#comments Fri, 23 Oct 2009 14:19:04 +0000 Mike Cole http://otcmorningcall.com/?p=424 bcliBrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) is a company developing stem cell therapeutic products based on breakthrough technologies. BrainStorm’s core technology, NurOwn™, was developed through a collaboration between prominent neurologist, Prof. Eldad Melamed, Head of Neurology of the Rabin Medical Center and member of the Scientific Committee of Michael J. Fox Foundation for Parkinson’s Research and expert cell biologist Dr. Daniel Offen, at the Felsenstein Medical Research Center of Tel-Aviv University.

This scientific team is among the first to have successfully demonstrated the physiological release of dopamine from in vitro differentiated bone marrow cells. Moreover, in research conducted by this team, implantation of these cells into the brains of animal models that had been induced to Parkinsonian behavior markedly improved their symptoms. BrainStorm intends to apply the patent-pending technology to the development of innovative autologous cell therapeutic products, NurOwn™, for treatment of neurological diseases.

BrainStorm holds exclusive worldwide rights to commercialize the NurOwn™ technology, through a licensing agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University. The agreement also provides for further research, funded by BrainStorm, to be performed by Prof. Melamed, Dr. Offen and members of their research team at the Felsenstein Medical Research Center. The results of this research are licensed to the Company under the terms of the license agreement. Thus, although a development stage company, BrainStorm has access to the research results of an R&D team comprising 12 experts in the technology, including molecular and cell biologists, pharmacologists and animal model experts.

The Company’s efforts are directed at the development of the technology from the lab to the clinic with the main objectives:

* Developing the cell differentiation process according to FDA guidelines.
* Demonstrating safety and efficacy first in animals and then in patients.
* Setting up centralized facilities to provide NurOwn™ therapeutic products and services for transplantation in patients.

The Company intends to enter into strategic partnerships as it progresses towards advanced clinical development and commercialization.

BrainStorm Cell Therapeutics Inc.
110 East 59th Street
New York NY 10022
Tel: (212)-557-9000

Stock Symbol: BCLI

Website: http://brainstorm-cell.com

]]> http://www.otcmorningcall.com/2009/10/brainstorm-cell-therapeutics-inc-otcbb-bcli/feed/ 0 OTCBB Stock of the Day http://www.otcmorningcall.com/2009/10/otcbb-stock-of-the-day/ http://www.otcmorningcall.com/2009/10/otcbb-stock-of-the-day/#comments Fri, 23 Oct 2009 13:50:14 +0000 Mike Cole http://otcmorningcall.com/?p=420 bcliToday’s OTC Stock of the day is BrainStorm Cell Therapeutics Inc. (BCLI). BCLI seems to be poised to move higher with resistance at around $0.50. If it is able to break and close above this point BrainStorm Cell Therapeutics Inc. should run much higher.

We have this stock on our watch list and may only consider it as a good entry after it break through resistance.

Note: We have not been compensated nor do we own any shares of BCLI. It is advised that you do your own DD before trading any stock on with website or any other websites.

]]> http://www.otcmorningcall.com/2009/10/otcbb-stock-of-the-day/feed/ 0 Stock Market Too Rise? http://www.otcmorningcall.com/2009/09/stock-market-too-rise/ http://www.otcmorningcall.com/2009/09/stock-market-too-rise/#comments Thu, 03 Sep 2009 13:17:10 +0000 Mike Cole http://otcmorningcall.com/?p=322 future9-3After several days of loses the futures market is currently to the upside just before the open.

Many traders are waiting for tomorrow’s major news announcement, the jobs numbers (Non-farm payroll).

Despite the downward pressure in the major markets, the OTCBB market has had some major winners. BrainStorm Cell Therapeutics Inc. (BCLI) gained 61.90% while Nutra Pharma Corp. (NPHC) rose 50% during yesterdays trading session.

We do not have a stock today that we have our eyes on. The stocks mentioned in the last couple weeks are the ones on our screen.

Remember, always, always do your own DD before investing in any stock.

]]> http://www.otcmorningcall.com/2009/09/stock-market-too-rise/feed/ 0